Vadivarhe Speciality Chemicals (VSCL)₹24.550.00%Specialty Chemicals
In the Mar 2026 quarter (standalone), Vadivarhe Speciality Chemicals reported sales of ₹28.70 Cr, up 22.7% from Mar 2025, and net profit of ₹2.22 Cr. For the year to Mar 2026, sales were ₹45.72 Cr and net profit −₹1.65 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 22.27 | 14.08 | 25.96 | 14.44 | 23.39 | 17.01 | 28.70 |
| Expenses | 20.61 | 15.03 | 21.07 | 16.44 | 27.96 | 19.53 | 25.70 |
| Operating Profit | 1.73 | −0.90 | 4.92 | −1.93 | −4.46 | −2.45 | 3.07 |
| OPM % | 7.9% | −6.4% | 19.1% | −13.4% | −19.1% | −14.4% | 10.8% |
| Other Income | 0.81 | 0.18 | 0.29 | 0.10 | 0.21 | 0.27 | 0.65 |
| Interest | 0.68 | 0.70 | 0.56 | 0.57 | 0.74 | 0.72 | 0.61 |
| Depreciation | 0.88 | 0.86 | 0.85 | 0.88 | 0.94 | 0.94 | 0.89 |
| Profit before tax | 0.99 | −2.31 | 3.82 | −3.31 | −5.97 | −3.87 | 2.23 |
| Tax % | 0.0% | 63.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Exceptional items | 0.38 | 0.00 | 0.00 | 0.00 | 0.07 | 0.08 | 0.26 |
| Net Profit | 0.99 | −3.76 | 3.82 | −3.31 | −5.98 | −3.86 | 2.22 |
| EPS (Rs) | 0.76 | −2.92 | 2.97 | −2.57 | −4.65 | −3.00 | 1.72 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.00 | 26.24 | 34.98 | 25.52 | 32.30 | 28.55 | 26.43 | 21.40 | 43.58 | 40.05 | 37.83 | 45.72 |
| Expenses | 11.55 | 18.94 | 24.70 | 21.84 | 30.03 | 37.88 | 27.06 | 28.30 | 40.28 | 35.52 | 43.86 | 45.25 |
| Operating Profit | 7.48 | 7.37 | 10.35 | 3.74 | 2.38 | −9.20 | −0.53 | −6.76 | 3.45 | 4.58 | −5.86 | 0.59 |
| OPM % | 39.6% | 28.2% | 29.7% | 14.8% | 7.5% | −32.3% | −2.0% | −31.6% | 8.0% | 11.6% | −15.5% | 1.3% |
| Other Income | 0.10 | 0.13 | 1.04 | 0.44 | 0.39 | 0.36 | 1.07 | 0.65 | 1.08 | 0.46 | 0.18 | 0.94 |
| Interest | 0.88 | 1.20 | 0.84 | 0.76 | 1.10 | 1.36 | 1.31 | 1.68 | 1.60 | 1.82 | 1.71 | 1.33 |
| Depreciation | 1.08 | 1.35 | 1.13 | 1.26 | 1.62 | 1.74 | 1.80 | 1.78 | 1.78 | 1.73 | 1.84 | 1.84 |
| Profit before tax | 5.65 | 4.97 | 9.47 | 2.18 | 0.06 | −12.00 | −2.60 | −9.62 | 1.16 | 1.51 | −9.29 | −1.65 |
| Tax % | 29.6% | 13.5% | 36.5% | 18.4% | −20.0% | −18.0% | 6.5% | 0.0% | 0.0% | 96.6% | 0.0% | 0.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 3.99 | 4.31 | 6.03 | 1.78 | 0.07 | −9.87 | −2.77 | −9.64 | 1.16 | 0.07 | −9.30 | −1.65 |
| EPS (Rs) | 82.24 | 88.68 | 4.96 | 1.39 | 0.04 | −7.71 | −2.15 | −7.51 | 0.89 | 0.04 | −7.24 | −1.27 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.86 | 4.85 | 12.12 | 12.82 | 12.82 | 12.82 | 12.82 | 12.82 | 12.82 | 12.82 | 12.82 | 12.82 |
| Reserves | 9.67 | 12.62 | 11.37 | 14.62 | 14.70 | 4.86 | 2.10 | −7.49 | −6.35 | −6.28 | −15.54 | −17.17 |
| Borrowings | 11.26 | 10.67 | 12.76 | 9.68 | 21.01 | 19.72 | 23.49 | 24.46 | 26.98 | 26.21 | 36.07 | 31.80 |
| Other Liabilities | 3.69 | 5.11 | 9.55 | 7.14 | 9.33 | 14.02 | 8.88 | 11.94 | 13.05 | 8.93 | 9.48 | 11.36 |
| Total Liabilities | 29.48 | 33.25 | 45.80 | 44.26 | 57.86 | 51.42 | 47.29 | 41.73 | 46.50 | 41.68 | 42.83 | 38.81 |
| Fixed Assets | 15.04 | 13.98 | 17.15 | 19.71 | 26.13 | 25.26 | 26.05 | 24.36 | 23.41 | 21.64 | 22.49 | 21.10 |
| CWIP | 0.00 | 0.00 | 0.08 | 1.57 | 1.87 | 2.80 | 0.32 | 1.08 | 0.98 | 1.55 | 0.07 | 0.18 |
| Investments | 0.04 | 0.04 | 0.04 | 0.04 | 0.06 | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Other Assets | 14.40 | 19.23 | 28.53 | 22.94 | 29.80 | 23.30 | 20.88 | 16.25 | 22.07 | 18.45 | 20.23 | 17.49 |
| Inventories | 1.23 | 2.43 | 1.97 | 3.08 | 6.61 | 6.82 | 3.33 | 6.81 | 8.56 | 8.57 | 9.71 | 7.95 |
| Trade receivables | 3.71 | 8.47 | 15.33 | 8.63 | 12.73 | 8.18 | 9.12 | 2.03 | 5.78 | 4.95 | 8.27 | 8.12 |
| Cash & equivalents | 1.38 | 0.49 | 0.12 | 0.82 | 0.59 | 0.67 | 0.99 | 0.81 | 0.82 | 0.53 | 0.58 | 0.70 |
| Total Assets | 29.48 | 33.25 | 45.80 | 44.26 | 57.86 | 51.42 | 47.29 | 41.73 | 46.50 | 41.68 | 42.83 | 38.81 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 5.29 | 3.19 | 2.10 | 7.17 | −1.23 | 4.12 | −0.29 | 1.25 | −0.36 | 2.27 | −7.18 | 6.39 |
| Cash from investing activity | −0.17 | −0.63 | −4.32 | −5.31 | −8.26 | −1.67 | 0.01 | −0.81 | −0.68 | −0.50 | −1.31 | −0.62 |
| Cash from financing activity | −4.02 | −3.44 | 1.89 | −1.13 | 9.28 | −2.35 | 0.59 | −0.61 | 1.06 | −2.05 | 8.56 | −5.63 |
| Net cash flow | 1.06 | −0.88 | −0.36 | 0.69 | −0.22 | 0.07 | 0.31 | −0.17 | 0.00 | −0.28 | 0.04 | 0.11 |
| Capex | 0.19 | 0.68 | 3.67 | 5.48 | 8.44 | 1.78 | 0.12 | 0.91 | 0.75 | 0.89 | 1.39 | 0.71 |
| Free cash flow | 5.08 | 2.50 | −1.60 | 1.82 | −9.64 | 2.32 | −0.40 | 0.36 | −1.12 | 1.73 | −8.51 | 5.70 |
| CFO / OP % | 70.0% | 44.0% | 35.0% | 208.0% | −48.0% | −44.0% | 20.0% | −18.0% | −10.0% | 81.0% | 121.1% | 1,060.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 71 | 118 | 160 | 123 | 143 | 104 | 126 | 34 | 48 | 45 | 80 | 65 |
| Inventory days | 223 | 118 | 63 | 172 | 223 | 123 | 78 | 169 | 122 | 148 | 129 | 109 |
| Days payable | 50 | 108 | 116 | 120 | 175 | 205 | 153 | 219 | 146 | 123 | 99 | 113 |
| Cash conversion cycle | 244 | 127 | 106 | 174 | 191 | 22 | 51 | −15 | 24 | 71 | 110 | 61 |
| Working capital days | 16 | 43 | 63 | 86 | 90 | −31 | 11 | −107 | −33 | 15 | −28 | −64 |
| ROCE % | 25.8% | 22.6% | 29.7% | 7.9% | 2.9% | −25.1% | −5.3% | −24.0% | 7.6% | 10.2% | −22.6% | −2.0% |
For the Mar 2026 quarter, Vadivarhe Speciality Chemicals reported sales of ₹28.70 Cr, up 22.7% year on year and net profit of ₹2.22 Cr. The operating margin was 10.8%.
Vadivarhe Speciality Chemicals' sales for the year to Mar 2026 were ₹45.72 Cr.
Net profit for the year to Mar 2026 was −₹1.65 Cr. Earnings per share over the same trailing period were ₹−1.27.
Vadivarhe Speciality Chemicals reported borrowings of ₹31.80 Cr at Mar 2026, against cash and equivalents of ₹0.70 Cr.
Cash from operations was ₹6.39 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹5.70 Cr.